Growth Metrics

Dexcom (DXCM) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -9.44%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 19.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -36.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.99%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.52%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.25%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 8.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.52%
Dec 31, 2025 -15.12%
Sep 30, 2025 25.30%
Jun 30, 2025 -6.05%
Mar 31, 2025 8.12%
Dec 31, 2024 -49.67%
Sep 30, 2024 -24.52%
Jun 30, 2024 -6.76%
Mar 31, 2024 5.07%
Dec 31, 2023 -11.52%
Sep 30, 2023 -1.50%
Jun 30, 2023 31.12%
Mar 31, 2023 2.15%
Dec 31, 2022 12.91%
Sep 30, 2022 20.84%
Jun 30, 2022 1.22%
Mar 31, 2022 -17.71%
Dec 31, 2021 -2.54%
Sep 30, 2021 57.82%
Jun 30, 2021 56.87%
Mar 31, 2021 20.40%
Dec 31, 2020 22.80%
Sep 30, 2020 27.23%
Jun 30, 2020 10.21%
Mar 31, 2020 56.16%
Dec 31, 2019 67.76%
Sep 30, 2019 59.39%
Jun 30, 2019 100.87%
Mar 31, 2019 154.57%
Dec 31, 2018 136.37%
Sep 30, 2018 62.70%
Jun 30, 2018 64.29%
Mar 31, 2018 97.95%
Dec 31, 2017 83.20%
Sep 30, 2017 72.96%
Jun 30, 2017 99.98%
Mar 31, 2017 49.76%
Dec 31, 2016 29.81%
Sep 30, 2016 43.02%
Jun 30, 2016 45.85%
Mar 31, 2016 60.33%
Dec 31, 2015 119.87%
Sep 30, 2015 162.79%
Jun 30, 2015 124.29%
Mar 31, 2015 119.86%
Dec 31, 2014 202.26%
Sep 30, 2014 53.36%
Jun 30, 2014 13.46%
Mar 31, 2014 129.01%
Dec 31, 2013 106.58%
Sep 30, 2013 82.12%
Jun 30, 2013 66.68%